Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: ads123 / Re: From the PR ... Has anyone tried to look these up yet

"Here is what I wish that we knew now---what was involved in the settlement with us and Apple?????? "

Your comment seems to imply that you think there was some hidden agenda or some additional consideration in the Apple license "settlement". Keep in mind, the only "settlement" between us and Apple, was a multi-portfolio license that TPL/Alliacense signed with Apple that in the end assigned a disproportionately LOW value to the MMP portfolio when compared to the other ones that were included. So, I'm not sure why you think there might be some hidden issues in the Apple "settlement".

As a reminder of what occured, TPL/Alliacense licensed Apple to SEVERAL of their portfolios at the same time, the MMP being only one of them. In those negotiations, it seems they originally assigned the largest value of the overall license fee to the MMP, however, when the deal was finally consumated, the MMP proportion of the fee was relegated to relatively miniscule amounts.

These "negotiations" revealed at least a couple of things that PTSC had been privately complaining to TPL about though had never taken legal action on in the past. One, that TPL/Alliacense showed that it was comingling its other portfolio licensing efforts with those of the MMP, and consequently, the costs associated with those efforts and charging them to PDS, and two, that TPL/Alliacense was discounting the MMP at the expense of its other portfolios.

After similar prior behavior was revealed in a public filing by HTC around the same time that the Apple license was signed, PTSC decided they had to file suit AGAINST TPL, regarding these issues. PTSC's motives behind that filing at THAT time can be argued since it was clear from the HTC filing as well as other "circumstantial" evidence that the practice wasn't a new practice, but ultimately, the bottom line is they DID fight back against TPL, and while "roaring publicly" about the issues in some "similarly aggressive" PR's to yesterday's, they ultimatley whimpered to a settlement with TPL (NOT Apple) that didn't really accomplish much for PTSC, though it appears as though it may have resulted in additional monies from the license being assigned to the MMP, and thus put on the PDS balance sheet. Better than nothing, but in the end, that money ultimately went back to TPL to pay for expenses, and thus never really made it to PTSC's balance sheet based on looking at the court filings and subsequent PR's, and SEC filings.

The issues with the Apple MMP license fee being discounted were not due to "other consideration" that Apple may have agreed to with respect to action down the road, but rather it was simply due to TPL's final breakdown and fee allotment to the MMP. The Apple deal was essentially just another run of the mill MMP license in the string of 94 or so that have been signed. Considering it's with the most valuable company in the world, it was disappointing that we never heard about it officially, or that it diddn't reflect a much larger fee collected, but there's nothing that I've read or seen in filings that would lead one to conclude that it represents anything more than a standard MMP license. Is there anything that you have seen that would lead you to conclude there's something more to it?

Share
New Message
Please login to post a reply